**December 2023 Update**
The Central B2 Pharmacy has ended its Ketamine order restriction for research studies โ including all projects involving animals.
Study Teams may also continue to purchase Ketamine through U-M approved external vendors.
If you have any questions, please contact the U-M Controlled Substances Monitoring Program at [email protected]
A nationwide shortage of the anesthetic drug Ketamine, first announced by the U-M Controlled Substances (CS) Monitoring Program in February 2023, continues to impact the Michigan Medicine B2 Pharmacy.
![Vial of Ketamine Hydrochloride with Update Banner](https://animalcare.umich.edu/wp-content/uploads/2023/11/acu_ketamine-shortage-update.png)
To prioritize human patient care amid this ongoing shortage, the B2 Pharmacy has extended its Ketamine order restrictions for U-M researchers โ including all animal users โ through October 2023.
Study Teams needing to order Ketamine for animal use during this time are encouraged to reach out to the U-Mโs approved vendor, MWI Animal Health, to purchase supplies. Instructions for setting up an account to order through MWI can be found on the Animal Care & Use Program website.
A complete list of U-M-approved vendors for other laboratory and research-related supplies is available on the U-M Procurement Services website.
Where to Get Help
- For more information about this shortage, please contact the CS Monitors at [email protected].
- Questions or concerns about seeking alternative medication options for the animals in your research program(s) should be directed to your ULAM Faculty Veterinarian.